Harness Therapeutics

About:

Harness Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.

Website: https://www.harnesstx.com/

Top Investors: Dementia Discovery Fund, SV Health Investors, Epidarex Capital, Takeda Ventures

Description:

Harness Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currently hard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. We have a particular focus on CNS and opthalmologic disorders but our platform has applications in multiple therapy areas